focus -WSS

focus

author：hotspot 2025-10-04 08:32:33 - browse：8

Launching your first clinical trial is the type of announcement most biotech executives eagerly anticipate, hoping to celebrate with employees. But for Celsius Therapeutics CEO Tariq Kassum, it’s proving to be more difficult than he anticipated.

That’s because in recent days, Celsius, based in Cambridge, Mass., has been forced to conduct a round of layoffs, sources told STAT. Kassum confirmed around 75% of Celsius’ 40-person team had been laid off, and disclosed that the biotech has also been quietly paring back its pipeline this year. It shut down almost all early-stage research projects, including pausing all of its cancer drug work, in order to conserve enough cash for the Phase 1 trial it announced this week.

“It’s an incredibly bittersweet moment.… The cognitive dissonance there is just really, really hard,” Kassum told STAT. “But I do think that you’re seeing a lot of other companies doing what we are, which is, as painful as it is, to focus on the nearest term value drivers, the things that can get to patients the quickest, and make the painful decisions that allow you to live to fight another day.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How to save PrEP access — and even expand it
Next article： What health policies could hitch a ride on a spending bill?

WSS

'Vaccine

Ohio still needs to do more to protect the right to abortion

5 ways to address the shortage of health care workers

Virtual repurposing can help discover new uses for existing drugs

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Type 2 diabetes prevention programs work at large scale: study

knowledge

focus

Wikipedia

Alkermes shareholders re

Are embryos people? Reproductive medicine's future depends on the answer

United colonoscopy coverage change 'may cost lives,' doctors say

First transplant of an entire human eye performed

Walensky prepares to leave CDC — and Congress — behind

Medical school prerequisites are outdated

Alkermes shareholders re

Ohio still needs to do more to protect the right to abortion

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare Advantage isn’t working — for anyone

hotspot

Using force crossed my mind when examining a defiant young patient

NIH chief: government has fallen behind pharma on clinical trials

Doctor of U.S. President Joe Biden says he is fit for duty

Cancer diagnosis changes perspective doctor, former hospital CEO

Neuroscience renaissance leads to new crop of psychiatric drugs

CDC panel: People 65 and older should get a Covid spring booster shot

explore

focus

entertainment

entertainment